Galapagos (GLPG) announced that its board of directors had decided to explore all strategic alternatives for its cell therapy business, including a potential divestiture of the Cell Therapy Business, ...
PHILADELPHIA, PA — Cabaletta Bio, Inc. (Nasdaq: CABA) has revealed significant progress in its pipeline and operations, underscoring its focus on advancing rese-cel, a cell therapy candidate for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback